CD68 and coronary atherosclerosis: This correlation may further strengthen the ability of NIRF-IVUS to serve as an unbiased tool for the detection of relevant pathophysiological risk criteria of human coronary atherosclerosis, such as the accumulation of CD68-positive inflammatory cells.